Literature DB >> 6799723

Rapid fractionation of human high density apolipoproteins by high performance liquid chromatography.

D Polacek, C Edelstein, A M Scanu.   

Abstract

A simple and rapid fractionation procedure (30 min) has been developed for the isolation of the major apoproteins from human serum high density lipoproteins by molecular sieving in a high performance liquid chromatographic column. Apo A-I, apoA-II and the C peptides are quantitatively resolved up to a protein load of 3 mg. The technique has also been successfully applied to the final purification of A apoproteins which had been isolated by conventional chromatographic procedures and as a sensitive analytical tool for assessing apoprotein purity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6799723     DOI: 10.1007/BF02534999

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  7 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  On the subunit structure of the protein of human serum high density lipoprotein. II. A study of Sephadex fraction IV.

Authors:  A M Scanu; C T Lim; C Edelstein
Journal:  J Biol Chem       Date:  1972-09-25       Impact factor: 5.157

3.  On the subunit structure of the protein of human serum high density lipoprotein. I. A study of its major polypeptide component (Sephadex, fraction 3).

Authors:  C Edelstein; C T Lim; A M Scanu
Journal:  J Biol Chem       Date:  1972-09-25       Impact factor: 5.157

4.  Cyanate formation in solutions of urea. I. Calculation of cyanate concentrations at different temperature and pH.

Authors:  P Hagel; J J Gerding; W Fieggen; H Bloemendal
Journal:  Biochim Biophys Acta       Date:  1971-09-28

5.  Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins.

Authors:  A M Scanu; C Edelstein
Journal:  Anal Biochem       Date:  1971-12       Impact factor: 3.365

6.  Separation of the apoprotein components of human very low density lipoproteins by ion-paired, reversed-phase high performance liquid chromatography.

Authors:  W S Hancock; C A Bishop; A M Gotto; D R Harding; S M Lamplugh; J T Sparrow
Journal:  Lipids       Date:  1981-04       Impact factor: 1.880

7.  Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.

Authors:  A Scanu; J Toth; C Edelstein; S Koga; E Stiller
Journal:  Biochemistry       Date:  1969-08       Impact factor: 3.162

  7 in total
  5 in total

1.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Authors:  B S Horowitz; I J Goldberg; J Merab; T M Vanni; R Ramakrishnan; H N Ginsberg
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.

Authors:  C Edelstein; J I Gordon; C A Vergani; A L Catapano; V Pietrini; A M Scanu
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

Review 4.  Chromatography of complex protein mixtures.

Authors:  F E Regnier
Journal:  J Chromatogr       Date:  1987-07-17

5.  Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.

Authors:  H N Ginsberg; C Ngai; X J Wang; R Ramakrishnan
Journal:  Arterioscler Thromb       Date:  1993-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.